secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nexentis Technologies Inc. (NXTS)
CIK:        0001789192
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001493152-25-011380
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

N2OFF amends MitoCareX acquisition: extends closing deadline, updates share counts and consideration caps
--------------------------------------------------------------------------------

- Outside Date extended by 90 days to 270 days from original agreement date (Feb 25, 2025).
- Fully-diluted share count updated to 32,808,629 (from 27,734,248) to reflect issuances after execution.
- Additional consideration for sellers capped at $1.6M total, allocated 52.73% SciSparc, 31.51% Alon, 15.76% Ciro.
- Post-closing N2OFF shares outstanding projected at 56,939,836, up from current 30,096,412 (increase ~26.8M).
- Milestone-based Additional Purchaser Stock of up to 25% of post-closing fully-diluted capital, vesting by Dec 31, 2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789192/000149315225011380/0001493152-25-011380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789192/000149315225011380/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer